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Background
Specific cell therapy with tolerogenic Dendritic Cells
(tolDCs) loaded with autoantigens is a promising tool
for the attenuation of pathogenic T cells in autoimmune
diseases such as Multiple Sclerosis (MS).
The aim of this study was to analyse the in vitro effect of
tolerogenic bone marrow derived DCs (BM-DCs) loaded
with Myelin Oligodendrocyte Glycoprotein (MOG) 40-55
peptide from C57BL/6 mice, on the specific proliferation
of splenocytes of mice with EAE.
Methods
Chronic EAE was induced in C57BL/6 mice by s.c. immu-
nization with MOG40-55 emulsified in complete Freund’s
adjuvant. Pertussis Toxin was injected i.v. at days 0 and 2
post-immunization to increase blood-brain-barrier perme-
ability. Clinical score was daily measured based on tail/leg
paralysis.
TolBM-DCs were in vitro differenciated with GM-CSF
in the presence of vitamin D3 (VD3) for 8 days.
On day 7, maturation was induced with LPS. Viability,
efficiency of differentiation and phenotype of tolBM-DCs
were evaluated. To assess antigen specificity, tolBM-DCs
were pulsed with MOG40-55, after the maturation stimu-
lus (day 7) for 18h and cocultured with syngeneic spleno-
cytes from mice with established EAE.
Results
TolBM-DCs displayed a semi-mature phenotype, exhib-
ited by low levels of MHC class II and coestimulatory
molecules (CD40, CD86) compared to control mature
BM-DCs (mBM-DCs) differenciated in the absence of
VD3. MOG40-55 loaded TolDCs showed to be poor sti-
mulators of specific T cells of mice with EAE, compared
to mBM-DCs.
Conclusion
These results suggest that MOG-loaded TolDCs may be
a powerful tool to induce specific T-cell hyporesponsive-
ness in mice with chronic MOG-induced EAE. Hence,
treatment with tolDCs loaded with myelin peptides
might be a potential therapy for EAE/MS.
Author details
1Immunobiology Laboratory For Research And Diagnostic Applications
(LIRAD-BST), Badalona, Spain. 2Multiple Sclerosis Unit, Dept. of Neurosciences,
Germans Trias i Pujol University Hospital (HUGTiP) and Health Science
Research Institute (IGTP), Badalona, Spain. 3Dept. of Immunology, Hospital
Vall d’Hebron, Barcelona, Spain. 4Universitat Autònoma Barcelona, (UAB),
Spain.
Published: 28 November 2012
doi:10.1186/1479-5876-10-S3-P27
Cite this article as: Sellés-Moreno et al.: Tolerogenic dendritic cells in
experimental autoimmune encephalomyelitis, specific
tolerance induction? Journal of Translational Medicine 2012 10(Suppl 3):
P27.
1Immunobiology Laboratory For Research And Diagnostic Applications
(LIRAD-BST), Badalona, Spain
Full list of author information is available at the end of the article
Sellés-Moreno et al. Journal of Translational Medicine 2012, 10(Suppl 3):P27
http://www.translational-medicine.com/content/10/S3/P27
© 2012 Sellés-Moreno et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
